RON PHARM(SHANGHAI)CO.,LIMITED
|
CycloLab started as a spin-off of Sanofi-Aventis Chinoin Pharma (1990) Over 40-year experience in all fields of CD-technology.
CycloLab produce sulfobutylether beta-cyclodextrin (SBECD, Dexolve™) in multiple ton scale annually under cGMP conditions based on an FDA-approved Drug Master File and CTD Format Dossier
DexolveTM is used in commercialand development phases for over 20 APIs by dozens of clients.
CycloLab's business model is free from license, milestone- and royalty payments |
Send Inquiry
|